Clinical Trials

Showing trials with last updates posted in 2017.

NCT02238925 | COMPLETED | PHASE2
26 participants

An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

Study Type:
INTERVENTIONAL
Last Updated:
2017-11-30
Start Date:
2014-07-31
Completion:
2015-05-31
Conditions
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Myelodysplastic Syndrome (MDS)
Interventions
  • DRUG
NCT01985802 | COMPLETED | NA
20 participants

Pacing in First-degree AV-block

Study Type:
INTERVENTIONAL
Last Updated:
2017-11-30
Start Date:
2015-12-31
Completion:
2017-10-26
Conditions
  • First-degree AV-block
  • Pacing
Interventions
  • OTHER
No Results Yet
NCT01653028 | COMPLETED | PHASE2
72 participants

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2017-11-30
Start Date:
2012-08-22
Completion:
2015-08-02
Conditions
  • Myxofibrosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Recurrent Leiomyosarcoma
  • Recurrent Liposarcoma
  • Recurrent Malignant Peripheral Nerve Sheath Tumor
  • Recurrent Undifferentiated Pleomorphic Sarcoma
  • Stage III Soft Tissue Sarcoma AJCC v7
  • Stage IV Soft Tissue Sarcoma AJCC v7
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page